Lexicon Pharma (LXRX) Tops Q4 EPS by 24c
Tweet
Share
E-mail
Get Alerts LXRX Hot Sheet
Price: $2.32 -0.85%
EPS Growth %: -600.0%
Financial Fact:
Collaborative research: 27.69M
Today's EPS Names:
CRMT, More
EPS Growth %: -600.0%
Financial Fact:
Collaborative research: 27.69M
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
Lexicon Pharma (NASDAQ: LXRX) reported Q4 EPS of ($0.04), $0.24 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $200 thousand versus the consensus estimate of $110 thousand.
For earnings history and earnings-related data on Lexicon Pharma (LXRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- SWBI beats estimates by 71%, GEO nears 52-week high on policy tailwinds
- SAS CEO van der Werff emerges as frontrunner for Air Canada top job - Bloomberg
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
